Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Establishing and Maintaining Lists of U.S. Milk Product Manufacturers/Processors With Interest in Exporting, 46074-46075 [2017-21212]
Download as PDF
46074
Federal Register / Vol. 82, No. 190 / Tuesday, October 3, 2017 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2014–N–0192]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Establishing and
Maintaining Lists of U.S. Milk Product
Manufacturers/Processors With
Interest in Exporting
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by November
2, 2017.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–7285, or emailed to oira_
submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–0509. Also
include the FDA docket number found
in brackets in the heading of this
document.
FOR FURTHER INFORMATION CONTACT: Ila
S. Mizrachi, Office of Operations, Food
and Drug Administration, Three White
Flint North, 10A–12M, 11601
Landsdown St., North Bethesda, MD
20852, 301–796–7726, PRAStaff@
fda.hhs.gov.
SUMMARY:
In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
SUPPLEMENTARY INFORMATION:
asabaliauskas on DSKBBXCHB2PROD with NOTICES
Establishing and Maintaining Lists of
U.S. Milk Product Manufacturers/
Processors With Interest in Exporting—
21 U.S.C. 371
OMB Control Number 0910–0509—
Extension
The United States exports a large
volume and variety of foods in
international trade. For certain food
products, foreign governments may
require assurances from the responsible
authority of the country of origin of an
VerDate Sep<11>2014
16:49 Oct 02, 2017
Jkt 244001
imported food that the processor of the
food is in compliance with applicable
country of origin regulatory
requirements. With regard to U.S. milk
products, FDA is the competent U.S.
food safety authority to provide this
information to foreign governments.
FDA provides the requested information
about processors in the form of lists,
which are provided to the foreign
governments and posted online at
https://www.fda.gov/Food/
GuidanceRegulation/ImportsExports/
Exporting/default.htm.
Currently, FDA provides Chile, China,
and the European Union (EU) with a list
of U.S. milk product manufacturers/
processors that: (1) Have expressed
interest in exporting their products to
these countries; (2) are subject to FDA’s
jurisdiction; and (3) are not the subject
of a pending enforcement action (i.e., an
injunction or seizure or a pending
warning letter).
FDA has published guidance
documents for these countries under the
authority of section 701(h) of the
Federal, Food, Drug, and Cosmetic Act
(21 U.S.C. 371(h)), which authorizes the
Secretary of Health and Human Services
(the Secretary) to develop guidance
documents with public participation
presenting the views of the Secretary on
matters under the jurisdiction of FDA.
The guidance documents explain
what information manufacturers/
processors should submit to FDA to be
considered for inclusion on the lists and
what criteria FDA intends to use to
determine eligibility for placement on
the lists. The guidance documents also
explain how FDA intends to update the
list and communicate any new
information to the government that
requested the list. Finally, the guidance
documents note that the information is
provided voluntarily by manufacturers/
processors with the understanding that
it will be posted on FDA’s external Web
site and communicated to, and possibly
further disseminated by, the government
that requested the list; thus, FDA
considers the information on the lists to
be information that is not protected
from disclosure under 5 U.S.C.
552(b)(4).
Application for inclusion on each list
is voluntary. However, some foreign
governments may require inclusion on
the list for acceptance of imported food.
FDA recommends that U.S.
manufacturers/processors that want to
be placed on the export lists send FDA
the following information: (1) Country
to which the milk manufacturer/
processor wants to export product; (2)
type of milk product facility; (3) the
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
Food Facility Registration Module
number (the information collected by
this module is approved under OMB
control number 0910–0502); (4) name
and address of the firm and the
manufacturing plant; (5) name,
telephone number, and email address of
the contact person; (6) list of products
divided into three categories: Presently
shipped, ready to ship, and available for
shipment in the next 3 years; (7)
identities of Agencies that inspected the
plant; (8) date of last inspection, plant
number, and copy of last inspection
notice; and (9) if other than an FDA
inspection, copy of last inspection
report.
We request that this information be
updated every 2 years.
We use the information submitted by
firms to determine their eligibility for
placement on the export lists, which are
published on our Web site. The purpose
of the lists is to help foreign
governments in their determinations of
which U.S. milk product manufacturers
and processors are eligible to export to
their respective countries.
FDA has recently developed an
electronic registry system (Form FDA
3972) that allows milk product
manufacturers and processors to
electronically send a request to FDA to
be included on the export lists.
Manufacturers and processors that
prefer to submit a paper request in a
format of their own choosing will still
have the option to do so. Electronic
Form FDA 3972 collects the same
information as is currently collected via
the existing paper-based process. Draft
screenshots of Form FDA 3972 and
instructions are available at https://
www.fda.gov/Food/
GuidanceRegulation/ImportsExports/
Exporting/ucm496929.htm and is
entitled ‘‘Dairy Listing Module.’’
Description of Respondents:
Respondents to this collection of
information include U.S. milk product
manufacturers/processors subject to
FDA jurisdiction that wish to export to
certain foreign countries that require
inclusion on export lists.
In the Federal Register of June 15,
2017 (82 FR 27485), FDA published a
60-day notice requesting public
comment on the proposed collection of
information. We received three
comments, however, they were not
responsive to the four collection of
information topics solicited and
therefore will not be discussed in this
document.
FDA estimates the burden of this
collection of information as follows:
E:\FR\FM\03OCN1.SGM
03OCN1
Federal Register / Vol. 82, No. 190 / Tuesday, October 3, 2017 / Notices
46075
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
Number of
respondents
Activity
Number of
responses per
respondent
Total annual
responses
Average burden
per response
Total hours
New requests to be placed on the lists ...................
Biennial update ........................................................
Occasional updates .................................................
2,000
2,000
200
1
1
1
2,000
2,000
200
1 ................................
0.5 (30 minutes) ........
0.5 (30 minutes) ........
2,000
1,000
100
Total ..................................................................
........................
........................
........................
....................................
3,100
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
FDA bases its estimate on the number
of manufacturers/processors that have
submitted new written requests,
biennial updates, and occasional
updates over the past 10 years. The
estimate of the number of burden hours
it will take a manufacturer/processor to
gather the information needed to be
placed on the list or update its
information is based on FDA’s
experience with manufacturers/
processors submitting similar requests.
FDA believes that the information to be
submitted will be readily available to
manufacturers/processors. This
collection is also incorporating
information collected to maintain lists
of eligible exporters of dairy products
who wish to export to the EU from OMB
control number 0910–0320, ‘‘Request for
Information from U.S. Processors that
Export to the European Community.’’
FDA estimates that 2,000 firms will
average 60 minutes (1 hour) to submit
new requests for inclusion on the list,
2,000 firms will average 30 minutes (0.5
hour) to update their information every
2 years, and 200 firms will average 30
minutes (0.5 hour) to occasionally
update their information in this system.
We also believe that submission via the
electronic registry system will not affect
the burden estimates. An electronic
registry will enhance the ability of firms
to more efficiently request inclusion on
export lists. FDA calculates, therefore,
that the total burden for this collection
is 3,100 hours ((2,000 × 1) plus (2,000
× 0.5) plus (200 × 0.5)).
asabaliauskas on DSKBBXCHB2PROD with NOTICES
Dated: September 28, 2017.
Anna K. Abram,
Deputy Commissioner for Policy, Planning,
Legislation, and Analysis.
[FR Doc. 2017–21212 Filed 10–2–17; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2017–D–5767]
Abbreviated New Drug Applications for
Certain Highly Purified Synthetic
Peptide Drug Products That Refer to
Listed Drugs of Recombinant
Deoxyribonucleic Acid Origin; Draft
Guidance for Industry; Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of availability.
The Food and Drug
Administration (FDA or Agency) is
announcing the availability of a draft
guidance for industry entitled ‘‘ANDAs
for Certain Highly Purified Synthetic
Peptide Drug Products That Refer to
Listed Drugs of rDNA Origin.’’ The
Federal Food, Drug, and Cosmetic Act
(FD&C Act) permits any person to
submit to the FDA an abbreviated new
drug application (ANDA) to seek
approval to market a generic version of
a previously approved drug product.
This draft guidance is intended to assist
potential applicants in determining
when an application for a synthetic
peptide drug product (specifically
glucagon, liraglutide, nesiritide,
teriparatide, and teduglutide) that refers
to a previously approved peptide drug
product of recombinant
deoxyribonucleic acid (rDNA) origin
should be submitted as an ANDA rather
than as new drug application (NDA).
DATES: Submit either electronic or
written comments on the draft guidance
by December 4, 2017 to ensure that the
Agency considers your comment on this
draft guidance before it begins work on
the final version of the guidance.
ADDRESSES: You may submit comments
on any guidance at any time as follows:
SUMMARY:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
VerDate Sep<11>2014
16:49 Oct 02, 2017
Jkt 244001
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2017–D–5767 for ‘‘ANDAs for Certain
Highly Purified Synthetic Peptide Drug
Products That Refer to Listed Drugs of
rDNA Origin.’’ Received comments will
be placed in the docket and, except for
those submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday.
E:\FR\FM\03OCN1.SGM
03OCN1
Agencies
[Federal Register Volume 82, Number 190 (Tuesday, October 3, 2017)]
[Notices]
[Pages 46074-46075]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-21212]
[[Page 46074]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2014-N-0192]
Agency Information Collection Activities; Submission for Office
of Management and Budget Review; Comment Request; Establishing and
Maintaining Lists of U.S. Milk Product Manufacturers/Processors With
Interest in Exporting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
proposed collection of information has been submitted to the Office of
Management and Budget (OMB) for review and clearance under the
Paperwork Reduction Act of 1995.
DATES: Fax written comments on the collection of information by
November 2, 2017.
ADDRESSES: To ensure that comments on the information collection are
received, OMB recommends that written comments be faxed to the Office
of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer,
FAX: 202-395-7285, or emailed to oira_submission@omb.eop.gov. All
comments should be identified with the OMB control number 0910-0509.
Also include the FDA docket number found in brackets in the heading of
this document.
FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations,
Food and Drug Administration, Three White Flint North, 10A-12M, 11601
Landsdown St., North Bethesda, MD 20852, 301-796-7726,
PRAStaff@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has
submitted the following proposed collection of information to OMB for
review and clearance.
Establishing and Maintaining Lists of U.S. Milk Product Manufacturers/
Processors With Interest in Exporting--21 U.S.C. 371
OMB Control Number 0910-0509--Extension
The United States exports a large volume and variety of foods in
international trade. For certain food products, foreign governments may
require assurances from the responsible authority of the country of
origin of an imported food that the processor of the food is in
compliance with applicable country of origin regulatory requirements.
With regard to U.S. milk products, FDA is the competent U.S. food
safety authority to provide this information to foreign governments.
FDA provides the requested information about processors in the form of
lists, which are provided to the foreign governments and posted online
at https://www.fda.gov/Food/GuidanceRegulation/ImportsExports/Exporting/default.htm.
Currently, FDA provides Chile, China, and the European Union (EU)
with a list of U.S. milk product manufacturers/processors that: (1)
Have expressed interest in exporting their products to these countries;
(2) are subject to FDA's jurisdiction; and (3) are not the subject of a
pending enforcement action (i.e., an injunction or seizure or a pending
warning letter).
FDA has published guidance documents for these countries under the
authority of section 701(h) of the Federal, Food, Drug, and Cosmetic
Act (21 U.S.C. 371(h)), which authorizes the Secretary of Health and
Human Services (the Secretary) to develop guidance documents with
public participation presenting the views of the Secretary on matters
under the jurisdiction of FDA.
The guidance documents explain what information manufacturers/
processors should submit to FDA to be considered for inclusion on the
lists and what criteria FDA intends to use to determine eligibility for
placement on the lists. The guidance documents also explain how FDA
intends to update the list and communicate any new information to the
government that requested the list. Finally, the guidance documents
note that the information is provided voluntarily by manufacturers/
processors with the understanding that it will be posted on FDA's
external Web site and communicated to, and possibly further
disseminated by, the government that requested the list; thus, FDA
considers the information on the lists to be information that is not
protected from disclosure under 5 U.S.C. 552(b)(4).
Application for inclusion on each list is voluntary. However, some
foreign governments may require inclusion on the list for acceptance of
imported food. FDA recommends that U.S. manufacturers/processors that
want to be placed on the export lists send FDA the following
information: (1) Country to which the milk manufacturer/processor wants
to export product; (2) type of milk product facility; (3) the Food
Facility Registration Module number (the information collected by this
module is approved under OMB control number 0910-0502); (4) name and
address of the firm and the manufacturing plant; (5) name, telephone
number, and email address of the contact person; (6) list of products
divided into three categories: Presently shipped, ready to ship, and
available for shipment in the next 3 years; (7) identities of Agencies
that inspected the plant; (8) date of last inspection, plant number,
and copy of last inspection notice; and (9) if other than an FDA
inspection, copy of last inspection report.
We request that this information be updated every 2 years.
We use the information submitted by firms to determine their
eligibility for placement on the export lists, which are published on
our Web site. The purpose of the lists is to help foreign governments
in their determinations of which U.S. milk product manufacturers and
processors are eligible to export to their respective countries.
FDA has recently developed an electronic registry system (Form FDA
3972) that allows milk product manufacturers and processors to
electronically send a request to FDA to be included on the export
lists. Manufacturers and processors that prefer to submit a paper
request in a format of their own choosing will still have the option to
do so. Electronic Form FDA 3972 collects the same information as is
currently collected via the existing paper-based process. Draft
screenshots of Form FDA 3972 and instructions are available at https://www.fda.gov/Food/GuidanceRegulation/ImportsExports/Exporting/ucm496929.htm and is entitled ``Dairy Listing Module.''
Description of Respondents: Respondents to this collection of
information include U.S. milk product manufacturers/processors subject
to FDA jurisdiction that wish to export to certain foreign countries
that require inclusion on export lists.
In the Federal Register of June 15, 2017 (82 FR 27485), FDA
published a 60-day notice requesting public comment on the proposed
collection of information. We received three comments, however, they
were not responsive to the four collection of information topics
solicited and therefore will not be discussed in this document.
FDA estimates the burden of this collection of information as
follows:
[[Page 46075]]
Table 1--Estimated Annual Reporting Burden 1
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of
Activity Number of responses per Total annual Average burden per response Total hours
respondents respondent responses
--------------------------------------------------------------------------------------------------------------------------------------------------------
New requests to be placed on the lists...... 2,000 1 2,000 1......................................... 2,000
Biennial update............................. 2,000 1 2,000 0.5 (30 minutes).......................... 1,000
Occasional updates.......................... 200 1 200 0.5 (30 minutes).......................... 100
-----------------------------------------------------------------------------------------------------------
Total................................... .............. .............. .............. .......................................... 3,100
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.
FDA bases its estimate on the number of manufacturers/processors
that have submitted new written requests, biennial updates, and
occasional updates over the past 10 years. The estimate of the number
of burden hours it will take a manufacturer/processor to gather the
information needed to be placed on the list or update its information
is based on FDA's experience with manufacturers/processors submitting
similar requests. FDA believes that the information to be submitted
will be readily available to manufacturers/processors. This collection
is also incorporating information collected to maintain lists of
eligible exporters of dairy products who wish to export to the EU from
OMB control number 0910-0320, ``Request for Information from U.S.
Processors that Export to the European Community.''
FDA estimates that 2,000 firms will average 60 minutes (1 hour) to
submit new requests for inclusion on the list, 2,000 firms will average
30 minutes (0.5 hour) to update their information every 2 years, and
200 firms will average 30 minutes (0.5 hour) to occasionally update
their information in this system. We also believe that submission via
the electronic registry system will not affect the burden estimates. An
electronic registry will enhance the ability of firms to more
efficiently request inclusion on export lists. FDA calculates,
therefore, that the total burden for this collection is 3,100 hours
((2,000 x 1) plus (2,000 x 0.5) plus (200 x 0.5)).
Dated: September 28, 2017.
Anna K. Abram,
Deputy Commissioner for Policy, Planning, Legislation, and Analysis.
[FR Doc. 2017-21212 Filed 10-2-17; 8:45 am]
BILLING CODE 4164-01-P